Author Archives

Archive of the posts written by author : OwnTheFloat.
Jul
29

NTVA: Here’s Why I Invested in INTIVA BioPharma

To start with another obvious disclaimer: I own shares in NTVA, but I have not been compensated in any way, shape, or form to write this blog, Tweet, or “promote” in any way. As always, I’m writing a blog to relay the things…

Jul
24

OWCP: Chairman Letter to Shareholders on July 24, 2018

I’m simply going to copy/paste the official PR here and bold certain areas that I felt were interesting. To our Shareholders, The last period has been an important time for re-assessing our corporate strategy, consolidating our company and strengthening our abilities to execute…

Jul
12

OWCP: My Emotional, Financial Roller Coaster Thus Far!

Today OWCP reached a new 52-week Low at $0.182. It’s definitely possible tomorrow could be just as ugly. I don’t know why we’re seeing a rise in volume. I can only speculate it’s the “$5M investor” dumping some shares OR a couple of…

Jul
10

TSOI and BLEVF: Basic Due Diligence on New Positions for Swing Trade

After getting in and out of $AQXP within a couple of days ($2.71 to $2.88 personally), I saw Jason Spatafora bringing attention to $BLEVF, as it historically bounced around this range ($1.06 was my entry) to as much as 50% gains last time. Then,…

Jul
7

OWCP: The Due Diligence That Allowed Me To Be Patient

I’ve been relatively quiet about OWCP lately. Sure, I post about the news, but I haven’t offered much for due diligence or opinion lately. Honestly, I’ve just been content in waiting while I’ve been increasingly busy at ‘the day job’ as I help…

May
3

OWCP: $5 Million from Institutional Investor

According to a Form 8-K released on May 3rd, 2018, OWC Pharmaceutical Corp (OWCP) has received a $5 million investment from an Institutional Investor. On April 30, 2018, OWC Pharmaceutical Research Corp. (the “Registrant”) entered into and consummated a Securities Purchase Agreement (the “Agreement”)…

Apr
27

Motion to Dismiss: SEC vs. Friedland — 4/20 Update

For anybody curious, this is just a quick post to share an update I came across after signing up for “PACER” (https://pacer.psc.uscourts.gov) in order to access the public records in the court system. There was an update for Jeffrey Friedland’s case on 4/20/18…

Mar
24

ARLZ: Is The CEO Building Another Pharma Acquisition Target?

Aralez Pharmaceuticals was founded in 2015 with a headquarters in Mississauga, Ontario, Canada. At the current share price of $1.57, the company has a market cap of “only” $107 million. ARLZ has quite the portfolio of Cardio Health and Pain Management products. As reported…

Mar
5

OWCP: Dr. Stanley Hirsch Speaks with CEOlive

In case you didn’t listen to the whole interview or just didn’t pay close enough attention, I felt it necessary to point out the key takeaways. Dr. Hirsch spent most of the video talking about medical cannabis in general, the research aspect, and…

Feb
20

OWCP: New Chief Scientific Officer – Dr. Yacoby Zeevi (PR)

On February 18, 2018, OWC Pharmaceutical Research Corp appointed Dr. Oron Yacoby Zeevi as its Chief Scientific Officer (CSO) and Dr. Yehuda Baruch, who was OWC’s CSO, will now serve as Chief Medical and Regulatory Officer. Brief Intro via 8K Filing: Dr. Oron…